SkyePharma Solaraze
Executive Summary
Diclofenac gel, 3%, approved for actinic keratoses Oct. 16. The company is in discussions with a potential North American marketing partner. The gel should be applied to lesion areas twice daily; the recommended duration of therapy is from 60 to 90 days. The NDA (21-005) was filed Oct. 22, 1998